We report a case of a patient with Guacher’s disease type III, with mutation in Exon9, 1246G> A and 1251G> C, seeking to investigate the suspected glaucoma, to describe the ophthalmological findings, as glycolipid accumulation in the pre-retinal region and to investigate The possible correlation with the decrease of the layer of nerve fibers.

The aim of this review is to list the ophthalmological conditions in which platelet concentrate (CP) has been used, as well as its biochemical and physiological properties. The CP has both anticatabolic potential, present in autologous serum, and substances with anabolic properties, which together are responsible for its benefits in the treatment of ocular surface diseases. There is currently a shortage of clinical trials in this area, both in ophthalmology and other medical areas, with more studies and reports on […]

Purpose: To perform an epidemiological study of eye diseases in the population of four indigenous communities in the City of Avai in the state of São Paulo – Brazil: Ekeruá, Kopenoti, Nimuendaju and Tereguá. Methods: This is a prospective, cross-sectional, population-based study performed by the Medical Residency Program of the Center of Excellence in Ophthalmology (CEO-Bauru), including all the inhabitants of four indigenous tribes, between the months of March and April 2016. All participants were submitted to a complete eye […]

Objetivo: Fazer um estudo epidemiológico das afecções oculares da população de quatro aldeias indígenas da cidade de Avaí, no estado de São Paulo – Brasil: Ekeruá, Kopenoti, Nimuendaju e Tereguá. Métodos: Estudo prospectivo, transversal realizado pelo serviço de residência médica da Clínica CEO-Bauru, em que foram incluídos todos os habitantes de quatro tribos indígenas, entre os meses de março a abril de 2016. Todos os participantes foram submetidos ao exame oftalmológico completo que incluía refração e medida da acuidade visual […]

Objective: Therapeutic evaluation of Bevacizumab application in relapsed pterygium concerning visual acuity, keratometry, refraction, symptomatology. Methods: Group 1 (4 patients) received 0.1 ml of Bevacizumab (avastin), being evaluated posteriorly on the tenth and thirtieth days after the application, seeking to compare with the exam previously made, being it realized with the other two groups, in which Group 2 (4 patients) received 0.2 ml of Bevacizumab and the Group 3 (3 patients) received 1 ml of the placebo injection. Results: In […]

Objetivo: Avaliação terapêutica da aplicação de bevacizumabe em pterígio recidivado com relação a acuidade visual, ceratometria, refração, sintomatologia. Métodos: O Grupo 1 (4 pacientes) recebeu 0,1ml de bevacizumabe (avastin) sendo avaliado posteriormente, nos dias 10 e 30 após a aplicação, buscando-se comparar com o exame previamente realizado, sendo o mesmo realizado com os outros dois grupos, em que o Grupo 2 (04 pacientes) recebeu 0,2ml de bevacizumabe e o grupo 3 (3 pacientes) recebeu 0,1 de injeção placebo. Resultados: Neste […]

Objectives: To describe and analyze the profile of children with developmental disorders treated at early intervention services (IP) and their mothers or caregivers, focusing on aspects related to the child’s ocular health. Methods: Quantitative survey, exploratory-descriptive. The data collection instrument consisted of a questionnaire applied with mothers or caregivers of children assisted in IP services. The data were transcribed in Microsoft Excel spreadsheet and analyzed based on simple descriptive statistics. The sample consisted of 273 subjects. Results: There was a […]